3Caballero AE. Endothelial dysfunction in obesity and insulin resis- tance :A road to diabetes and heart disease[ J ]. Obes Res, 2003,11 (11) :1278-1289.
4Balletshofer BM, Rittig K, Enderle MD, et al. Endothelial dysfunc-tion is detectable in young noemotentive first-degree relatives of sub- jects with type 2 dibetes in association with insulin resistance [ J ]. Circulation, 2000, ( I 01 ) : 1780 -1784.
5Willa H, Simon J, Ronald EL, et al. Control of vascular cell pro- liferation and migration by PPAR-：/[ J ]. Diabetes Care, 2001,24 (2) :392-397.
6Natali A, Baldeweg S, Toschi E, et al. Vascular effects of ira-pro- ving metabolic control with metfonnin or rosiglitazone in type2diabetes [J]. Diabetes Care, 2004,27 (6) : 1349-1357.
7Boyle PJ, King AB, Olansky L, et al. Effects of pioglitazone and rosiglitazone on blood lipid levels and glycemic control in pa-tients with type2diabetes mellitus:a retrospective review of randomly se- lected medical records[J]. Clin Ther, 2002,24 (3) :378-396.
